Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Screening colonoscopy and flexible sigmoidoscopy for reduction of colorectal cancer incidence: A case-control study.

Ko CW, Doria-Rose VP, Barrett MJ, Kamineni A, Enewold L, Weiss NS.

PLoS One. 2019 Dec 5;14(12):e0226027. doi: 10.1371/journal.pone.0226027. eCollection 2019.

2.

Staging Laparoscopy is Underutilized in the Management of Gastric Adenocarcinoma.

Groh EM, Gupta S, Brown ZJ, Enewold L, Gamble LA, Hernandez JM, Davis JL.

Ann Surg Oncol. 2020 May;27(5):1473-1479. doi: 10.1245/s10434-019-08077-1. Epub 2019 Nov 20.

PMID:
31749079
3.

Expected Monetary Impact of Oncotype DX Score-Concordant Systemic Breast Cancer Therapy Based on the TAILORx Trial.

Mariotto A, Jayasekerea J, Petkov V, Schechter CB, Enewold L, Helzlsouer KJ, Feuer EJ, Mandelblatt JS.

J Natl Cancer Inst. 2020 Feb 1;112(2):154-160. doi: 10.1093/jnci/djz068.

PMID:
31165854
4.

Screening flexible sigmoidoscopy versus colonoscopy for reduction of colorectal cancer mortality.

Ko CW, Doria-Rose VP, Barrett MJ, Kamineni A, Enewold L, Weiss NS.

Int J Colorectal Dis. 2019 Jul;34(7):1273-1281. doi: 10.1007/s00384-019-03300-7. Epub 2019 May 31.

5.

Black/white differences in treatment and survival among women with stage IIIB-IV breast cancer at diagnosis: a US population-based study.

Enewold L, Penn DC, Stevens JL, Harlan LC.

Cancer Causes Control. 2018 Jul;29(7):657-665. doi: 10.1007/s10552-018-1045-9. Epub 2018 Jun 2.

PMID:
29860614
6.

Patterns of care and survival among patients with malignant mesothelioma in the United States.

Enewold L, Sharon E, Thomas A.

Lung Cancer. 2017 Oct;112:102-108. doi: 10.1016/j.lungcan.2017.08.009. Epub 2017 Aug 10.

7.

Creating a National Provider Identifier (NPI) to Unique Physician Identification Number (UPIN) Crosswalk for Medicare Data.

Parsons HM, Enewold LR, Banks R, Barrett MJ, Warren JL.

Med Care. 2017 Dec;55(12):e113-e119. doi: 10.1097/MLR.0000000000000462.

8.

Examining colorectal cancer survivors' surveillance patterns and experiences of care: a SEER-CAHPS study.

Mollica MA, Enewold LR, Lines LM, Halpern MT, Schumacher JR, Hays RD, Gibson JT, Schussler N, Kent EE.

Cancer Causes Control. 2017 Oct;28(10):1133-1141. doi: 10.1007/s10552-017-0947-2. Epub 2017 Sep 2.

PMID:
28866818
9.

Metastatic Melanoma: Treatment and Survival in the US after the Introduction of Ipilimumab and Vemurafenib.

Enewold L, Sharon E, Harlan LC.

Oncol Res Treat. 2017;40(4):174-183. doi: 10.1159/000456014. Epub 2017 Mar 9.

10.

Metastatic lung cancer in the age of targeted therapy: improving long-term survival.

Del Rivero J, Enewold L, Thomas A.

Transl Lung Cancer Res. 2016 Dec;5(6):727-730. doi: 10.21037/tlcr.2016.11.08.

11.

Temporal patterns of care and outcomes of non-small cell lung cancer patients in the United States diagnosed in 1996, 2005, and 2010.

Kaniski F, Enewold L, Thomas A, Malik S, Stevens JL, Harlan LC.

Lung Cancer. 2017 Jan;103:66-74. doi: 10.1016/j.lungcan.2016.11.020. Epub 2016 Nov 29.

12.

Associations between cancer and Alzheimer's disease in a U.S. Medicare population.

Freedman DM, Wu J, Chen H, Kuncl RW, Enewold LR, Engels EA, Freedman ND, Pfeiffer RM.

Cancer Med. 2016 Oct;5(10):2965-2976. doi: 10.1002/cam4.850. Epub 2016 Sep 14.

13.

Pathogenesis and progression of oesophageal adenocarcinoma varies by prior diagnosis of Barrett's oesophagus.

Cook MB, Drahos J, Wood S, Enewold L, Parsons R, Freedman ND, Taylor PR, Ricker W, Abnet CC.

Br J Cancer. 2016 Nov 22;115(11):1383-1390. doi: 10.1038/bjc.2016.344. Epub 2016 Oct 25.

14.

Real-World Patterns of EGFR Testing and Treatment with Erlotinib for Non-Small Cell Lung Cancer in the United States.

Enewold L, Thomas A.

PLoS One. 2016 Jun 13;11(6):e0156728. doi: 10.1371/journal.pone.0156728. eCollection 2016.

15.

Comprehensive Evaluation of Medical Conditions Associated with Risk of Non-Hodgkin Lymphoma using Medicare Claims ("MedWAS").

Engels EA, Parsons R, Besson C, Morton LM, Enewold L, Ricker W, Yanik EL, Arem H, Austin AA, Pfeiffer RM.

Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1105-13. doi: 10.1158/1055-9965.EPI-16-0212. Epub 2016 Apr 26.

16.

Associations between cancer and Parkinson's disease in U.S. elderly adults.

Freedman DM, Wu J, Chen H, Engels EA, Enewold LR, Freedman ND, Goedert JJ, Kuncl RW, Gail MH, Pfeiffer RM.

Int J Epidemiol. 2016 Jun;45(3):741-51. doi: 10.1093/ije/dyw016. Epub 2016 Mar 17.

17.

Differential Serum Cytokine Levels and Risk of Lung Cancer Between African and European Americans.

Pine SR, Mechanic LE, Enewold L, Bowman ED, Ryan BM, Cote ML, Wenzlaff AS, Loffredo CA, Olivo-Marston S, Chaturvedi A, Caporaso NE, Schwartz AG, Harris CC.

Cancer Epidemiol Biomarkers Prev. 2016 Mar;25(3):488-97. doi: 10.1158/1055-9965.EPI-15-0378. Epub 2015 Dec 28.

18.

Oncotype Dx assay and breast cancer in the United States: usage and concordance with chemotherapy.

Enewold L, Geiger AM, Zujewski J, Harlan LC.

Breast Cancer Res Treat. 2015 May;151(1):149-56. doi: 10.1007/s10549-015-3366-7. Epub 2015 Apr 10.

PMID:
25859924
19.

Pancreatic cancer in the USA: persistence of undertreatment and poor outcome.

Enewold L, Harlan LC, Tucker T, McKenzie S.

J Gastrointest Cancer. 2015 Mar;46(1):9-20. doi: 10.1007/s12029-014-9668-x.

PMID:
25403828
20.

Thyroid cancer presentation and treatment in the United States.

Enewold L, Harlan LC, Stevens JL, Sharon E.

Ann Surg Oncol. 2015;22(6):1789-97. doi: 10.1245/s10434-014-4209-1. Epub 2014 Nov 1.

21.

Adjuvant radioactive iodine use among differentiated thyroid cancer patients in the military health system.

Gill AA, Enewold L, Zahm SH, Shriver CD, Zheng L, McGlynn KA, Zhu K.

Mil Med. 2014 Sep;179(9):1043-50. doi: 10.7205/MILMED-D-13-00540.

22.

Colon cancer treatment: are there racial disparities in an equal-access healthcare system?

Gill AA, Enewold L, Zahm SH, Shriver CD, Stojadinovic A, McGlynn KA, Zhu K.

Dis Colon Rectum. 2014 Sep;57(9):1059-65. doi: 10.1097/DCR.0000000000000177.

23.

Breast reconstruction after mastectomy among Department of Defense beneficiaries by race.

Enewold LR, McGlynn KA, Zahm SH, Poudrier J, Anderson WF, Shriver CD, Zhu K.

Cancer. 2014 Oct 1;120(19):3033-9. doi: 10.1002/cncr.28806. Epub 2014 Jun 25.

24.

The risk of amyotrophic lateral sclerosis after cancer in U.S. elderly adults: a population-based prospective study.

Freedman DM, Wu J, Daugherty SE, Kuncl RW, Enewold LR, Pfeiffer RM.

Int J Cancer. 2014 Oct 1;135(7):1745-50. doi: 10.1002/ijc.28795. Epub 2014 Feb 28.

25.

Socioeconomic disparities in colorectal cancer mortality in the United States, 1990-2007.

Enewold L, Horner MJ, Shriver CD, Zhu K.

J Community Health. 2014 Aug;39(4):760-6. doi: 10.1007/s10900-014-9824-z.

PMID:
24477390
26.

Surveillance mammography among female Department of Defense beneficiaries: a study by race and ethnicity.

Enewold L, McGlynn KA, Zahm SH, Jatoi I, Anderson WF, Gill AA, Shriver CD, Zhu K.

Cancer. 2013 Oct 1;119(19):3531-8. doi: 10.1002/cncr.28242. Epub 2013 Aug 1.

27.

Breast conserving surgery versus mastectomy: the influence of comorbidities on choice of surgical operation in the Department of Defense health care system.

Zhou J, Enewold L, Zahm SH, Jatoi I, Shriver C, Anderson WF, Jeffery DD, Andaya A, Potter JF, McGlynn KA, Zhu K.

Am J Surg. 2013 Sep;206(3):393-9. doi: 10.1016/j.amjsurg.2013.01.034. Epub 2013 Jul 16.

28.

Race and colon cancer survival in an equal-access health care system.

Andaya AA, Enewold L, Zahm SH, Shriver CD, Stojadinovic A, McGlynn KA, Zhu K.

Cancer Epidemiol Biomarkers Prev. 2013 Jun;22(6):1030-6. doi: 10.1158/1055-9965.EPI-13-0143. Epub 2013 Apr 10.

29.

Mammography screening by race/ethnicity among U.S. servicewomen, 2009-2010.

Enewold L, McGlynn KA, Shriver CD, Zhu K.

Mil Med. 2012 Dec;177(12):1513-8.

30.

SERPINA1 and ELA2 polymorphisms are not associated with COPD or lung cancer.

Enewold L, Mechanic LE, Bowman ED, Platz EA, Alberg AJ.

Anticancer Res. 2012 Sep;32(9):3923-8.

31.

Association of matrix metalloproteinase-1 polymorphisms with risk of COPD and lung cancer and survival in lung cancer.

Enewold L, Mechanic LE, Bowman ED, Platz EA, Alberg AJ.

Anticancer Res. 2012 Sep;32(9):3917-22.

32.

Lung cancer survival among black and white patients in an equal access health system.

Zheng L, Enewold L, Zahm SH, Shriver CD, Zhou J, Marrogi A, McGlynn KA, Zhu K.

Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1841-7. doi: 10.1158/1055-9965.EPI-12-0560. Epub 2012 Aug 16.

33.

Socioeconomic disparities and breast cancer hormone receptor status.

Andaya AA, Enewold L, Horner MJ, Jatoi I, Shriver CD, Zhu K.

Cancer Causes Control. 2012 Jun;23(6):951-8. doi: 10.1007/s10552-012-9966-1. Epub 2012 Apr 25.

PMID:
22527173
34.

Trends in testicular germ cell tumors among U.S. military servicemen, 1990-2003.

Enewold L, Zhou J, Devesa SS, Erickson RL, Zhu K, McGlynn KA.

Mil Med. 2011 Oct;176(10):1184-7.

35.

Thyroid cancer incidence among active duty U.S. military personnel, 1990-2004.

Enewold LR, Zhou J, Devesa SS, Berrington de Gonzalez A, Anderson WF, Zahm SH, Stojadinovic A, Peoples GE, Marrogi AJ, Potter JF, McGlynn KA, Zhu K.

Cancer Epidemiol Biomarkers Prev. 2011 Nov;20(11):2369-76. doi: 10.1158/1055-9965.EPI-11-0596. Epub 2011 Sep 13.

36.

Racial variation in tumor stage at diagnosis among Department of Defense beneficiaries.

Enewold L, Zhou J, McGlynn KA, Devesa SS, Shriver CD, Potter JF, Zahm SH, Zhu K.

Cancer. 2012 Mar 1;118(5):1397-403. doi: 10.1002/cncr.26208. Epub 2011 Aug 11.

37.

Colorectal, prostate, and skin cancer screening among Hispanic and White non-Hispanic men, 2000-2005.

Zhou J, Enewold L, Peoples GE, McLeod DG, Potter JF, Steele SR, Clive KS, Stojadinovic A, Zhu K.

J Natl Med Assoc. 2011 Apr;103(4):343-50.

PMID:
21805813
38.

Racial variation in breast cancer treatment among Department of Defense beneficiaries.

Enewold L, Zhou J, McGlynn KA, Anderson WF, Shriver CD, Potter JF, Zahm SH, Zhu K.

Cancer. 2012 Feb 1;118(3):812-20. doi: 10.1002/cncr.26346. Epub 2011 Jul 15.

39.

Racial disparities in histopathologic characteristics of uterine cancer are present in older, not younger blacks in an equal-access environment.

Oliver KE, Enewold LR, Zhu K, Conrads TP, Rose GS, Maxwell GL, Farley JH.

Gynecol Oncol. 2011 Oct;123(1):76-81. doi: 10.1016/j.ygyno.2011.06.027. Epub 2011 Jul 7.

PMID:
21741078
40.

Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer.

Pine SR, Mechanic LE, Enewold L, Chaturvedi AK, Katki HA, Zheng YL, Bowman ED, Engels EA, Caporaso NE, Harris CC.

J Natl Cancer Inst. 2011 Jul 20;103(14):1112-22. doi: 10.1093/jnci/djr216. Epub 2011 Jun 17.

41.

Melanoma incidence rates among whites in the U.S. Military.

Zhou J, Enewold L, Zahm SH, Devesa SS, Anderson WF, Potter JF, McGlynn KA, Zhu K.

Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):318-23. doi: 10.1158/1055-9965.EPI-10-0869. Epub 2010 Dec 8.

42.

Trends in cancer screening among Hispanic and white non-Hispanic women, 2000-2005.

Zhou J, Enewold L, Peoples GE, Clifton GT, Potter JF, Stojadinovic A, Zhu K.

J Womens Health (Larchmt). 2010 Dec;19(12):2167-74. doi: 10.1089/jwh.2009.1909. Epub 2010 Nov 1.

PMID:
21039233
43.

Oral contraceptive use among women in the military and the general U.S. population.

Enewold L, Brinton LA, McGlynn KA, Zahm SH, Potter JF, Zhu K.

J Womens Health (Larchmt). 2010 May;19(5):839-45. doi: 10.1089/jwh.2009.1706.

44.

Incidence rates of exocrine and endocrine pancreatic cancers in the United States.

Zhou J, Enewold L, Stojadinovic A, Clifton GT, Potter JF, Peoples GE, Zhu K.

Cancer Causes Control. 2010 Jun;21(6):853-61. doi: 10.1007/s10552-010-9512-y. Epub 2010 Feb 25. Erratum in: Cancer Causes Control. 2011 Sep;22(9):1353.

PMID:
20182788
45.

Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005.

Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE, Devesa SS.

Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):784-91. doi: 10.1158/1055-9965.EPI-08-0960. Epub 2009 Feb 24.

46.

Serum concentrations of cytokines and lung cancer survival in African Americans and Caucasians.

Enewold L, Mechanic LE, Bowman ED, Zheng YL, Yu Z, Trivers G, Alberg AJ, Harris CC.

Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):215-22. doi: 10.1158/1055-9965.EPI-08-0705.

47.

Common genetic variation in TP53 is associated with lung cancer risk and prognosis in African Americans and somatic mutations in lung tumors.

Mechanic LE, Bowman ED, Welsh JA, Khan MA, Hagiwara N, Enewold L, Shields PG, Burdette L, Chanock S, Harris CC.

Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):214-22.

48.

Less efficient g2-m checkpoint is associated with an increased risk of lung cancer in African Americans.

Zheng YL, Loffredo CA, Alberg AJ, Yu Z, Jones RT, Perlmutter D, Enewold L, Krasna MJ, Yung R, Shields PG, Harris CC.

Cancer Res. 2005 Oct 15;65(20):9566-73.

49.

TP53 mutation spectrum in lung cancer is not different in women and men.

Marrogi AJ, Mechanic LE, Welsh JA, Bowman ED, Khan MA, Enewold L, Shields PG, Harris CC.

Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):1031-3.

50.

Polymorphisms in XPD and TP53 and mutation in human lung cancer.

Mechanic LE, Marrogi AJ, Welsh JA, Bowman ED, Khan MA, Enewold L, Zheng YL, Chanock S, Shields PG, Harris CC.

Carcinogenesis. 2005 Mar;26(3):597-604. Epub 2004 Nov 25.

PMID:
15564288

Supplemental Content

Loading ...
Support Center